05.12.2018

‘Big place’ for small-molecule booster drugs in cancer immunotherapy, says NeoPhore CEO

APM Health: Interview with CEO, Jeff Roix

More news

NeoPhore's CEO - Michael Shih - recently presented the NeoPhore story at the Morgan Stanley Global Healthcare Conference on Monday September 8th…

NeoPhore appoints Michael Shih as Chief Executive Officer • Highly experienced corporate development leader with a track record of international p…

NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb Additional funding will be used to explore…